Previous Article | Next Article 
Infection and Immunity, December 1998, p. 5698-5702, Vol. 66, No. 12
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
TetR Is a Positive Regulator of the Tetanus Toxin
Gene in Clostridium tetani and Is Homologous to
BotR
Jean-Christophe
Marvaud,1
Ulrich
Eisel,2
Thomas
Binz,3
Heiner
Niemann,3 and
Michel
R.
Popoff1,*
Unité des Toxines Microbiennes,
Institut Pasteur, 75724 Paris Cedex 15, France,1
and
Institut für Zellbiologie und Immunologie,
University of Stuttgart, 70569 Stuttgart,2
and
Institut für Biochemie, Medizinische Hochschule,
30623 Hannover,3 Germany
Received 6 July 1998/Returned for modification 20 August
1998/Accepted 8 September 1998
 |
ABSTRACT |
The TetR gene immediately upstream from the tetanus toxin (TeTx)
gene was characterized. It encodes a 21,562-Da protein which is related
(50 to 65% identity) to the equivalent genes (botR) in
Clostridium botulinum. TetR has the feature of a DNA
binding protein with a basic pI (9.53). It contains a helix-turn-helix motif and shows 29% identity with other putative regulatory genes in
Clostridium, i.e., uviA from C. perfringens and txeR from C. difficile.
We report for the first time the transformation of C. tetani by electroporation, which permitted us to investigate the
function of tetR. Overexpression of tetR in
C. tetani induced an increase in TeTx production and in the
level of the corresponding mRNA. This indicates that TetR is a
transcriptional activator of the TeTx gene. Overexpression of
botR/A (60% identity with TetR at the amino acid level) in
C. tetani induced an increase in TeTx production comparable
to that for overexpression of tetR. However,
botR/C (50% identity with TetR at the amino acid level) was less efficient. This supports that TetR positively regulates the
TeTx gene in C. tetani and that a conserved mechanism of
regulation of the neurotoxin genes is involved in C. tetani
and C. botulinum.
 |
INTRODUCTION |
Tetanus toxin (TeTx) and botulinum
neurotoxins (BoNTs) are the most potent protein toxins. They have
similar structures and modes of action at the molecular level, and they
are synthesized as single-chain proteins (approximately 150 kDa) which
are proteolytically activated to dichain derivatives involving a light
chain (L) (approximately 50 kDa) and a heavy chain (H) (approximately
100 kDa). Both chains remain linked by a single disulfide bridge. In
the culture supernatants and contaminated food, BoNTs are associated
with nontoxic proteins (ANTPs) to form complexes whose molecular sizes
range from 230 to 900 kDa. In contrast, TeTx does not form such
complexes (21). Certain ANTPs are hemagglutinins (HA). The
TeTx and BoNT genes in various strains have been characterized. In
Clostridium botulinum, the BoNT genes are localized in the
3' part of the C. botulinum locus and are preceded by
the gene encoding the nontoxic, non-HA component (NTNH). The HA genes
lie upstream of the NTNH-BoNT genes and are transcribed in the opposite
orientation. A gene encoding a 21- to 22-kDa protein is localized in
the 5' part of the C. botulinum locus in C. botulinum C and D (11, 17) or between the NTNH-BoNT and
HA genes in C. botulinum A, B, F, and G (1, 5, 6, 12,
13). This protein called BotR shows the feature of a
transcriptional regulator (basic pI [10.4] and the presence of
helix-turn-helix motifs), and it is related (25 to 28% identity according to the Bestfit program) to other regulatory proteins such as
UviA from Clostridium perfringens (10), a protein
(TxeR) from Clostridium difficile (16), and, to a
lesser extent, MsmR from Streptococcus mutans
(20). The txeR gene is located directly upstream
from the tcdB and tcdA genes encoding the
C. difficile toxins B and A, respectively, which are
responsible for the gastrointestinal disorders caused by this
bacterium. It was shown to be a positive regulator of tcdB
and tcdA gene promoters in Escherichia coli (16).
In Clostridium tetani, a gene homologous to botR
was found in the flanking regions of the TeTx gene. Thus, it was
reported that a DNA sequence upstream of the TeTx gene encodes 29 C-terminal amino acids homologous to BotR (1, 7, 8). No gene
related to those encoding NTNH and HA components of botulinum complexes was detected. Here, we report the complete characterization of tetR from C. tetani, and we report that TetR and
also BotR from C. botulinum A (BotR/A) and C. botulinum C (BotR/C) are positive regulators of TeTx gene
expression in C. tetani.
 |
MATERIALS AND METHODS |
Bacterial strains and plasmids.
C. tetani CN655 and
recombinant strains were grown in broth containing trypticase (30 g/liter), yeast extract (20 g/liter), glucose (5 g/liter), and
cysteine-HCl (0.5 g/liter) (pH 7.2) under anaerobic conditions.
Clostridium DNA was extracted and purified as previously
described (18).
DNA techniques.
Ligation, transformation, sequencing, and
preparation of plasmid DNA from E. coli were conducted by
standard procedures (22).
Transformation of C. tetani by electroporation.
Competent cells from C. tetani CN655 were prepared in an
anaerobic chamber. The bacteria of a Trypticase-glucose-yeast extract (TGY) culture (100 ml) were recovered by centrifugation in the middle
of the exponential growth phase, washed in distilled water, and
suspended in 0.5 ml of 7 mM Na2HPO4 (pH 7.4)
containing 1 mM MgCl2 and 270 mM sucrose. Plasmid DNA (1 to
5 µg) produced in E. coli HB101 was added to 50 µl of
cell suspension. Electroporation was performed outside the anaerobic
chamber with a Bio-Rad gene pulser (2.5 kV, 200
, and 25 µF) and a
hermetically sealed cuvette with an anaerobic atmosphere. The bacteria
were diluted in TGY, incubated for 3 h at 37°C, and plated onto
TGY agar containing 5 µg of erythromycin per ml in an anaerobic chamber.
Construction of plasmids for expression of tetR and
botR/C gene expression plasmids.
A DNA fragment
containing the coding region of tetR was amplified by PCR
from C. tetani CN655 with primers introducing a
NcoI site at the translational start codon and a
PstI site immediately downstream of the stop codon. The
amplification product cut by NcoI and PstI was
cloned into the high-copy-number vector pAT19 downstream of the
C. perfringens iota toxin gene promoter and upstream of the
3' part of the iota toxin ibp gene as previously described
(pMRP306) (15). The resulting plasmid, pMRP365, was transferred into C. tetani CN655 yielding the CN655-OE strain.
A similar construction was done with botR/C. The coding
region of botR/C was amplified by PCR from C. botulinum C 468 (11) by adding NcoI and
PstI sites at the 5' and 3' parts, respectively, and was
cloned into pMRP306 digested with NcoI-PstI. The
resulting plasmid (pMRP319) was transferred into C. tetani
CN655, yielding CN655-BotR/C.
RNA isolation and RNA dot blots.
Total RNA was extracted
from C. tetani cultures in the middle of the exponential
growth phase by using Trizol (GibcoBRL, Cergy Pontoise, France). The
bacterial pellet from a 10-ml culture (optical density at 600 nm
[OD600], 1.6 to 1.8) was washed twice in distilled water
and suspended in 200 µl of 10 mM Tris-HCl (pH 7)-10 mM EDTA-20% sucrose containing 1 mg of lysozyme. The mixture was incubated for 30 min at 37°C and centrifuged. The pellet was suspended in 1 ml of
Trizol, and the suspension was incubated for 5 min at room temperature.
The subsequent steps were performed according to the manufacturer's recommendations.
Serial dilutions of total RNA in 20× SSC (1× SSC is 0.15 M NaCl plus
0.015 M sodium citrate) were transferred onto Hybond N+
membranes (Amersham, Paris, France). The membranes were incubated at
60°C for 2 h in Rapid Hybridization Buffer (Amersham), with the
PCR-amplified fragments corresponding to the TeTx gene which were
32P labeled with the Megaprime kit (Amersham). The
membranes were washed in 0.1× SSC-0.1% sodium dodecyl sulfate at
60°C and exposed to X-ray films.
PAGE and immunoblotting procedure.
Proteins were
precipitated from the supernatant of cultures (OD, 1.8) of wild-type
and recombinant C. tetani strains with 10% trichloroacetic
acid. The precipitate was collected by centrifugation and was washed
with acetone. The solubilized proteins in 50 mM Tris-HCl (pH 8) and
serial dilutions were subjected to SDS-polyacrylamide gel
electrophoresis (PAGE) in a 10% acrylamide gel.
The immunoblotting procedure of Burnette (2) was used.
Proteins separated by 0.1% SDS-10% PAGE were transferred
electrophoretically to nitrocellulose sheets (Hybond C; Amersham). The
nitrocellulose sheets were incubated for 1 h in phosphate-buffered
saline containing 5% dried milk and were then incubated overnight at
room temperature with a 1:400 dilution of rabbit anti-TeTx antibodies.
Bound antibodies were detected with peroxidase-labeled protein A and
the chemiluminescence kit provided by Amersham.
Toxicity to mice.
Serial twofold dilutions of samples (0.5 ml) in 50 mM sodium phosphate buffer (pH 6.3) containing 0.2% (wt/vol)
gelatin were injected intraperitoneally into mice weighing 18 to 20 g.
Four mice were used for each dilution. The mice were observed over 4 days, and the numbers that died were recorded.
Nucleotide sequence accession number.
The nucleotide
sequence reported in this paper has been submitted to the EMBL Data
Library under accession no. AJ006534.
 |
RESULTS |
Characterization of the tetR gene.
Previous
reports of the TeTx nucleotide sequence indicated the presence of
tetR immediately upstream of the TeTx gene (7, 8). To obtain the complete sequence of tetR, we cloned
a 2.4-kbp HindIII/EcoRI fragment and
established the sequence of an area of 480 bp located upstream of the
previously reported sequence (8). The nucleotide sequence
and the deduced amino acid sequence of tetR are presented in
Fig. 1. TetR has a calculated molecular mass of 21,562 Da and consists of 178 amino acids. It displays 50 to
65% identity with the corresponding proteins of C. botulinum strains. A sequence alignment is shown in Fig.
2. TetR exhibits the characteristic
features of a DNA binding protein, i.e., a calculated basic pI (9.53)
and a helix-turn-helix motif, and shows significant homology to UviA
from C. perfringens and TxeR from C. difficile,
two other putative Clostridium regulatory proteins (Fig. 2).

View larger version (57K):
[in this window]
[in a new window]
|
FIG. 1.
Nucleotide and deduced amino acid sequences of TetR. The
amino acid sequence is shown in single-letter code below the nucleotide
sequence. The nontranslated regions upstream of the tetR and
between the tetR and TeTx open reading frames are indicated
by lowercase letters. Arrows identify the translational start codons of
tetR and the TeTx gene.
|
|

View larger version (109K):
[in this window]
[in a new window]
|
FIG. 2.
Alignment of TetR; BotRs from C. botulinum
A1, A2, B proteolytic (Bp), B nonproteolytic (Bnp), C, F proteolytic
(Fp), and G; and the related regulatory proteins from C. difficile (TxeR) and C. perfringens (UviA).
|
|
Overexpression of the tetR gene in C. tetani.
To analyze the function of TetR, the tetR gene
was overexpressed in C. tetani. A truncated promoter region
of tetR was present only in the 2.4-kbp
HindIII-EcoRI fragment and was too short to permit expression of the tetR gene. Thus, the coding
region of tetR was amplified by PCR and cloned into the
vector containing the promoter of the C. perfringens iap
gene, which was used for Clostridium gene expression
(15). The resulting plasmid, pMRP365, was transferred by
electroporation into C. tetani CN655, yielding CN655-OE.
TeTx production in the wild-type (CN655) and recombinant (CN655-OE)
strains was monitored by measuring mouse lethal activity. As shown in
Fig. 3, the lethal activity in the
culture supernatant during the exponential growth phase was higher (six
to eight times) in CN655-OE than that in the wild-type strain. The
increase in TeTx production by CN655-OE was confirmed by Western
blotting with specific antibodies against TeTx (Fig.
4). Transfection of pAT19 did not result
in an increase in TeTx production compared with the wild type (data not
shown). These data indicate that the tetR gene in high copy
number and in trans position in C. tetani induced
an increase in TeTx production. No other extracellular protein seemed
to be overproduced, as shown in Fig. 5.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 3.
Mouse lethal activity in culture supernatants of
wild-type C. tetani CN655 ( ) and recombinant strains
overexpressing the tetR ( ), botR/A ( ), and
botR/C ( ) genes. The mouse lethal activity
(LD50) is plotted against the OD600 for each
culture. The means and standard deviations of the values from two
experiments are indicated.
|
|

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 4.
Production of TeTx assayed by Western blotting with
anti-TeTx antibodies in wild-type C. tetani CN655 (A)
and in recombinant strains overexpressing the tetR
(CN655-OE) (B), botR/A (CN655-BotR/A) (C), and
botR/C (CN655-BotR/C) (D) genes. Supernatants of each
culture (OD600) were concentrated by trichloroacetic acid
precipitation, 20 µg of protein was loaded on lane 1, and serial
twofold dilutions were loaded in the subsequent lanes. In panels B and
D, the upper bands correspond to the whole TeTx and the lower bands
correspond to the H chain.
|
|

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 5.
PAGE of extracellular proteins (50 µg) of recombinant
strain overexpressing tetR (CN655-OE) (lane 1) and of
C. tetani wild-type CN655 (lane 2). H and L, heavy and
light chains of TeTx, respectively.
|
|
The specific mRNA of the TeTx gene was assayed by dot blot
analysis in the wild-type and recombinant CN655-OE strains. The amounts of TeTx gene-specific mRNAs were approximately four times higher than those in the wild-type strain (Fig.
6). This was in agreement with the
increase in the level of TeTx in culture supernatant quantified by
mouse lethal activity and immunoblotting. These results show that TetR
activates TeTx expression at the transcriptional level.

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 6.
mRNA dot blots from the wild-type strain CN655 (wt) and
from recombinant strains CN655-OE (OE), CN655-BotR/A (botR/A), and
CN655-botR/C (botR/C) with probes specific for the TeTx gene. The mRNA
was prepared from cultures at an OD600 of 1.4. The total
amounts of mRNA loaded in each lane are indicated in micrograms.
|
|
Overexpression of botR/A and botR/C genes
in C. tetani.
Since TetR shows a high similarity to the
equivalent regulatory genes (botRs) from C. botulinum, it was interesting to know if these genes of the same
family can be functionally interchangeable. BotR/A shows an overall
identity of 60% with TetR (Fig. 2). It was found that plasmid pMRP309
containing the botR/A gene under the control of its own
promoter induced a significant increase in the production of BoNT/A and
ANTPs and in the corresponding mRNAs in C. botulinum A
(15). C. tetani CN655 was transformed by
electroporation with pMRP309, yielding strain CN655-BotR/A. A
comparable increase in the amount of TeTx assayed by the mouse test and immunoblotting was observed during the exponential
growth phase of CN655-BotR/A and CN655-OE (Fig. 3 and 4). Mouse
lethal activity in the culture supernatant of CN655-OE and CN655-botR/A was approximately eight times higher than that in the wild-type strain
(Fig. 3). The overproduction of TeTx assayed by immunoblotting was
increased by approximately 16 times in CN655-OE and 8 times in
CN655-botR/A compared to the wild-type strain (Fig. 4). Moreover, the
amounts of mRNAs of the TeTx gene were increased (approximately four
times) in both strains (Fig. 6). This indicates that BotR/A was able to
positively regulate the TeTx gene in C. tetani.
The potential effect of BotR/C, which is less related to TetR at the
amino acid level (50% identity) than BotR/A (60% identity), in
C. tetani was investigated. Plasmid pMRP319,
corresponding to the pAT19 vector containing the coding region of
botR/C under the control of the iap gene promoter
(15), was transferred into C. tetani CN655
by electroporation (CN655-BotR/C). The production of TeTx assayed by
mouse lethal activity was three times higher in CN655-BotR/C than that
in the wild-type strain and was eight times higher as determined by
immunoblotting (Fig. 3 and 4). No significant increase in TeTx-specific
mRNA was detected in CN655-BotR/C (Fig. 6). This shows that
botR/C stimulated the expression of the TeTx gene, albeit at
a lower extent than botR/A.
 |
DISCUSSION |
We report the complete sequence of the tetR gene from
C. tetani, which is highly related to the
botR genes from C. botulinum A, B, C, D, F,
and G (1, 5, 6, 12, 13). TetR shows an overall level of
identity of from 50% with BotR/C to 65% with BotR/F. This family of
genes is related to other putative regulatory genes in
Clostridium, such as uviA in C. perfringens and txeR in C. difficile
(10, 16). TetR and the other related proteins possess the
features of DNA binding proteins, i.e., high pI (pH 9.53) and the
presence of a helix-turn-helix motif.
We succeeded in transforming C. tetani with pAT19,
which is a shuttle vector between gram-positive and gram-negative
bacteria and which contains a replication origin from
Enterococcus fecalis (23). The electroporation
conditions were similar to those used for the C. botulinum transformation (15). The present article is the first report of genetic transformation in C. tetani and construction of recombinant C. tetani strains to investigate a gene function in this microorganism.
Overexpression of tetR in trans position induces
an increase in TeTx production, as monitored by mouse lethality in
culture supernatant and by Western blotting. A corresponding
increase in the specific mRNA of the TeTx gene indicates that
tetR positively regulates the transcriptional level of the
toxin gene in C. tetani. It can not be ruled out that
tetR in cis position could be more efficient.
tetR seems to regulate specifically the TeTx gene and to
have no pleomorphic effect. We explored if the equivalent genes (botR) from C. botulinum are functional in
C. tetani. The high-copy-number vector pAT19 containing
botR/A or botR/C was transferred by
electroporation into C. tetani CN655. BotR/A, which is
more closely related to TetR than BotR/C, produced a higher increase in
TeTx production and in the specific mRNA, compared with BotR/C.
This shows that BotR/A and BotR/C are functional in C. tetani. The different levels of effect between BotR/A and BotR/C
could be due to a lower level of expression of botR/C, since
botR/C was under the control of the iap promoter
(pMRP365) and botR/A was under the control of its own
promoter (pMRP309). However, tetR was constructed under the
control of the iap promoter and induced an equivalent
activation of TeTx gene expression equivalent to that of
botR/A. The more distant relatedness of BotR/C to TetR
than to BotR/A could explain the reduced efficiency of BotR/C in
C. tetani. These data suggest a common mechanism of
regulation of the neurotoxin genes in C. tetani and
C. botulinum.
We found that BotR/A stimulates expression of both the BoNT and ANTP
genes (15). The
10 and
35 regions of the neurotoxin and
ANTP gene promoters in C. botulinum A, B, C, D, F, and
G and C. tetani contain conserved sequences (1,
12). Moreover, BotR/A seems to interact directly with the
promoter region and the conserved motifs could represent binding sites
for the regulatory proteins (15). TetR could be also a
regulatory protein which binds the promoter region of the TeTx gene.
Whether Tet/R and BotR are involved in a cascade of regulatory proteins
is unknown. It has been found that short peptides from casein
hydrolysates are important for toxinogenesis in C. tetani (19), but the environmental signals which
trigger neurotoxin production remain to be determined.
The presence of highly conserved genes in the close vicinity of the
clostridial neurotoxin genes, which are functionally interchangeable, constitutes additional evidence that the locus of clostridial neurotoxin genes derived from a common ancestor. However, the NTNH and
HA genes, which lie upstream from the BoNT genes in the different
C. botulinum toxinotypes, are missing in C. tetani. The tetR gene is the only ANTP gene which was
found in C. tetani.
Vaccination against tetanus is extremely effective in preventing
this disease, and widespread vaccination has almost eradicated tetanus from developed countries. Current tetanus vaccines are produced by formaldehyde treatment of TeTx produced by wild-type C. tetani to yield the immunogenic toxoid. A novel
generation of tetanus vaccines involves production of the
C-terminal part (fragment C) of TeTx, which is nontoxic and is able
to induce neutralizing antibodies. The production of large
quantities of recombinant fragment C in various organisms such as
E. coli, Lactococcus lactis,
Baculovirus, and Pichia pastoris (3, 4, 9,
14, 24) was attempted. Our findings on the genetic transformation of C. tetani and on the identification of TetR as a
positive regulator open the possibility of using C. tetani as an engineering system for vaccine production. It may be
possible to construct C. tetani strains which produce
large amounts of TeTx or fragment C. C. tetani has
the advantage of secreting a soluble form of TeTx, and this organism is
already used in industrial fermentation.
 |
ACKNOWLEDGMENTS |
This work was supported by a DRET contract (96-129) and a DRET
fellowship to J.C.M.
We thank P. Binder for supporting this project, E. Maguin for the gift
of shuttle vectors, G. Reysset for his help in anaerobic manipulations,
and R. Hurme for helpful advice.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Unité des
Toxines Microbiennes, Institut Pasteur, 28 rue du Dr. Roux, 75724 Paris Cedex 15, France. Phone: 33 1 45 68 83 07. Fax: 33 1 45 68 84 56. E-mail: mpopoff{at}pasteur.fr.
Editor:
D. L. Burns
 |
REFERENCES |
| 1.
|
Bhandari, M.,
K. D. Campbell,
M. D. Collins, and A. K. East.
1997.
Molecular characterization of the clusters of genes encoding the botulinum neurotoxin complex in Clostridium botulinum (Clostridium argentinense) type G and nonproteolytic Clostridium botulinum type B.
Curr. Microbiol.
35:207-214[Medline].
|
| 2.
|
Burnette, W. N.
1981.
Western-blotting: electrophoresis transfer of proteins from sodium dodecyl sulfate polyacrylamide gel to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.
Anal. Biochem.
112:115-203.
|
| 3.
|
Charles, I. G.,
B. C. Rodgers,
A. J. Makoff,
S. N. Chatfield,
D. E. Slater, and N. F. Fairweather.
1991.
Synthesis of tetanus toxin fragment C in insect cells by use of a Baculovirus expression system.
Infect. Immun.
59:1627-1632[Abstract/Free Full Text].
|
| 4.
|
Clare, J. J.,
F. B. Rayment,
S. P. Ballantine,
K. Sreekrishna, and M. A. Romanos.
1991.
High-level expression of tetanus toxin fragment C in Pichia pastoris strains containing multiple tandem integrations of the gene.
Bio/Technology
9:455-460[Medline].
|
| 5.
|
East, A. K.,
M. Bhandari,
J. M. Stacey,
K. D. Campbell, and M. D. Collins.
1996.
Organization and phylogenetic interrelationships of genes encoding components of the botulinum toxin complex in proteolytic Clostridium botulinum types A, B, and F: evidence of chimeric sequences in the gene encoding the nontoxic nonhemagglutinin component.
Int. J. Syst. Bacteriol.
46:1105-1112[Abstract/Free Full Text].
|
| 6.
|
East, A. K.,
J. M. Stacey, and M. Collins.
1994.
Cloning and sequencing of a hemagglutinin component of the botulinum neurotoxin complex encoded by Clostridium botulinum types A and B.
Syst. Appl. Microbiol.
17:306-312.
|
| 7.
|
Eisel, U.,
W. Jarausch,
K. Goretzki,
A. Henschen,
J. Engels,
U. Weller,
M. Hudel,
E. Habermann, and H. Niemann.
1986.
Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins.
EMBO J.
5:2495-2502[Medline].
|
| 8.
|
Fairweather, N. F., and V. A. Lyness.
1986.
The complete nucleotide sequence of tetanus toxin.
Nucleic Acids Res.
14:7809-7812[Free Full Text].
|
| 9.
|
Figueiredo, D.,
C. Turcotte,
G. Frankel,
Y. Li,
O. Dolly,
G. Wilkin,
D. Marriott,
N. Fairweather, and G. Dougan.
1995.
Characterization of recombinant tetanus toxin derivatives suitable for vaccine development.
Infect. Immun.
63:3218-3221[Abstract].
|
| 10.
|
Garnier, T., and S. T. Cole.
1988.
Studies of UV-inducible promoters from Clostridium perfringens in vivo and in vitro.
Mol. Microbiol.
2:607-614[Medline].
|
| 11.
|
Hauser, D.,
M. W. Eklund,
P. Boquet, and M. R. Popoff.
1994.
Organization of the botulinum neurotoxin C1 gene and its associated non-toxic protein genes in Clostridium botulinum C468.
Mol. Gen. Genet.
243:631-640[Medline].
|
| 12.
|
Henderson, I.,
S. M. Whelan,
T. O. Davis, and N. P. Minton.
1996.
Genetic characterization of the botulinum toxin complex of Clostridium botulinum strain NCTC2916.
FEMS Microbiol. Lett.
140:151-158[Medline].
|
| 13.
|
Li, B.,
X. Qian,
H. K. Sarkar, and B. R. Singh.
1998.
Molecular characterization of type E Clostridium botulinum and comparison to other types of Clostridium botulinum.
Biochim. Biophys. Acta
1395:21-27[Medline].
|
| 14.
|
Makoff, A. J.,
S. P. Ballantine,
A. E. Smallwood, and N. F. Fairweather.
1989.
Expression of tetanus toxin fragment C in E. coli: its purification and potential use as a vaccine.
Bio/Technology
7:1043-1046.
|
| 15.
|
Marvaud, J. C.,
M. Gibert,
K. Inoue,
V. Fujinaga,
K. Oguma, and M. R. Popoff.
1998.
botR is a positive regulator of botulinum neurotoxin and associated nontoxic protein genes in Clostridium botulinum A.
Mol. Microbiol.
29:1009-1018[Medline].
|
| 16.
|
Moncrief, J. S.,
L. A. Barroso, and T. D. Wilkins.
1997.
Positive regulation of Clostridium difficile toxins.
Infect. Immun.
65:1105-1108[Abstract].
|
| 17.
|
Ohyama, T.,
T. Watanabe,
Y. Fujinaga,
K. Inoue,
H. Sunagawa,
N. Fujii,
K. Inoue, and K. Oguma.
1995.
Characterization of nontoxic-nonhemagglutinin component of the two types of progenitor toxin (M and L) produced by Clostridium botulinum type C CB-16.
Microbiol. Immunol.
39:457-465[Medline].
|
| 18.
|
Popoff, M. R.,
J. P. Guillou, and J. P. Carlier.
1985.
Taxonomic position of lecithinase-negative strains of Clostridium sordellii.
J. Gen. Microbiol.
131:1697-1703[Medline].
|
| 19.
|
Porfirio, Z.,
S. M. Prado,
M. D. C. Vancetto,
F. Fratelli,
E. W. Alves,
I. Raw,
B. L. Fernandes,
A. C. M. Camargo, and I. Lebrun.
1997.
Specific peptides of casein pancreatic digestion enhance the production of tetanus toxin.
J. Appl. Microbiol.
83:678-684[Medline].
|
| 20.
|
Russell, R. B. B.,
J. Aduse-Opoku,
I. C. Sutcliffe,
L. Tao, and J. J. Ferretti.
1992.
A binding protein-dependent system in Streptococcus mutans responsible for multiple sugar-metabolism.
J. Biol. Chem.
267:4631-4637[Abstract/Free Full Text].
|
| 21.
|
Sakaguchi, G.,
I. Ohishi, and S. Kozaki.
1988.
Botulism structure and chemistry of botulinum, p. 191-216.
In
M. C. Hardegree, and A. T. Tu (ed.), Handbook of natural toxins, vol. 4. Marcel Dekker Inc., New York, N.Y.
|
| 22.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 23.
|
Trieu-Cuot, P.,
C. Carlier,
C. Poyart-Salmeron, and P. Courvalin.
1991.
Shuttle vectors containing a multiple cloning site and a lacZ gene for conjugal transfer of DNA from Escherichia coli to gram-positive bacteria.
Gene
102:99-104[Medline].
|
| 24.
|
Wells, J. M.,
P. W. Wilson,
P. M. Norton,
M. J. Gasson, and R. W. F. Le Page.
1993.
Lactococcus lactis: high level expression of tetanus toxin fragment C and protection against lethal challenge.
Mol. Microbiol.
8:1155-1162[Medline].
|
Infection and Immunity, December 1998, p. 5698-5702, Vol. 66, No. 12
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Jacobson, M. J., Lin, G., Raphael, B., Andreadis, J., Johnson, E. A.
(2008). Analysis of Neurotoxin Cluster Genes in Clostridium botulinum Strains Producing Botulinum Neurotoxin Serotype A Subtypes. Appl. Environ. Microbiol.
74: 2778-2786
[Abstract]
[Full Text]
-
Couesnon, A., Raffestin, S., Popoff, M. R.
(2006). Expression of botulinum neurotoxins A and E, and associated non-toxin genes, during the transition phase and stability at high temperature: analysis by quantitative reverse transcription-PCR.. Microbiology
152: 759-770
[Abstract]
[Full Text]
-
Plourde-Owobi, L., Seguin, D., Baudin, M.-A., Moste, C., Rokbi, B.
(2005). Molecular Characterization of Clostridium tetani Strains by Pulsed-Field Gel Electrophoresis and Colony PCR. Appl. Environ. Microbiol.
71: 5604-5606
[Abstract]
[Full Text]
-
Voth, D. E., Ballard, J. D.
(2005). Clostridium difficile Toxins: Mechanism of Action and Role in Disease. Clin. Microbiol. Rev.
18: 247-263
[Abstract]
[Full Text]
-
Lovenklev, M., Artin, I., Hagberg, O., Borch, E., Holst, E., Radstrom, P.
(2004). Quantitative Interaction Effects of Carbon Dioxide, Sodium Chloride, and Sodium Nitrite on Neurotoxin Gene Expression in Nonproteolytic Clostridium botulinum Type B. Appl. Environ. Microbiol.
70: 2928-2934
[Abstract]
[Full Text]
-
Karlsson, S., Dupuy, B., Mukherjee, K., Norin, E., Burman, L. G., Akerlund, T.
(2003). Expression of Clostridium difficile Toxins A and B and Their Sigma Factor TcdD Is Controlled by Temperature. Infect. Immun.
71: 1784-1793
[Abstract]
[Full Text]
-
Bruggemann, H., Baumer, S., Fricke, W. F., Wiezer, A., Liesegang, H., Decker, I., Herzberg, C., Martinez-Arias, R., Merkl, R., Henne, A., Gottschalk, G.
(2003). The genome sequence of Clostridium tetani, the causative agent of tetanus disease. Proc. Natl. Acad. Sci. USA
100: 1316-1321
[Abstract]
[Full Text]
-
Mani, N., Lyras, D., Barroso, L., Howarth, P., Wilkins, T., Rood, J. I., Sonenshein, A. L., Dupuy, B.
(2002). Environmental Response and Autoregulation of Clostridium difficile TxeR, a Sigma Factor for Toxin Gene Expression. J. Bacteriol.
184: 5971-5978
[Abstract]
[Full Text]
-
Mani, N., Dupuy, B.
(2001). Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor. Proc. Natl. Acad. Sci. USA
10.1073/pnas.101126598v1
[Abstract]
[Full Text]
-
Bull, T. J., Hermon-Taylor, J., Pavlik, I., El-Zaatari, F., Tizard, M.
(2000). Characterization of IS900 loci in Mycobacterium avium subsp. paratuberculosis and development of multiplex PCR typing. Microbiology
146: 2185-2197
[Abstract]
[Full Text]
-
Mani, N., Dupuy, B.
(2001). Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor. Proc. Natl. Acad. Sci. USA
98: 5844-5849
[Abstract]
[Full Text]